NO20053959L - Medikament omfattende hoy-aktiv langtidsvarende beta-2-aqonist i kombinasjon med andre aktive bestanddeler - Google Patents
Medikament omfattende hoy-aktiv langtidsvarende beta-2-aqonist i kombinasjon med andre aktive bestanddelerInfo
- Publication number
- NO20053959L NO20053959L NO20053959A NO20053959A NO20053959L NO 20053959 L NO20053959 L NO 20053959L NO 20053959 A NO20053959 A NO 20053959A NO 20053959 A NO20053959 A NO 20053959A NO 20053959 L NO20053959 L NO 20053959L
- Authority
- NO
- Norway
- Prior art keywords
- active ingredients
- combination
- active
- aqonist
- medication
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Foreliggende oppfinnelse omhandler anvendelse av en bronkodilator i kombinasjon med en eller flere ytterligere aktive ingredienser for behandling av luftveissykdommer og spesielt astma og kronisk obstruktiv pulmonalsykdom (SOPC) samt farmasøytiske sammensetninger inneholdende de aktive ingrediensene. Spesifikt omhandler oppfinnelsen anvendelse av den langtidsvirkende ß2-agonisten 8-hydroksy-5- [(1R) -1hydroksy-2[[(1R)-2-(4-metoksyfeny1)-1-methyletyl]amino]etyl-2(1H)-kinolin og/eller fysiologiske godtakbare salter og/eller solvater derav slik som en bronkoutvider i kombinasjon med andre aktive ingredienser.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03004184A EP1452179A1 (en) | 2003-02-27 | 2003-02-27 | Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid |
PCT/EP2004/001960 WO2004075896A1 (en) | 2003-02-27 | 2004-02-27 | Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20053959D0 NO20053959D0 (no) | 2005-08-25 |
NO20053959L true NO20053959L (no) | 2005-11-28 |
Family
ID=32748803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053959A NO20053959L (no) | 2003-02-27 | 2005-08-25 | Medikament omfattende hoy-aktiv langtidsvarende beta-2-aqonist i kombinasjon med andre aktive bestanddeler |
Country Status (32)
Country | Link |
---|---|
US (1) | US20070020190A1 (no) |
EP (3) | EP1452179A1 (no) |
JP (1) | JP2006519204A (no) |
KR (1) | KR20050104367A (no) |
CN (2) | CN100370986C (no) |
AR (1) | AR043419A1 (no) |
AT (1) | ATE401887T1 (no) |
AU (1) | AU2004216472B2 (no) |
BR (1) | BRPI0408047A (no) |
CA (1) | CA2517321A1 (no) |
CY (1) | CY1108360T1 (no) |
DE (1) | DE602004015260D1 (no) |
DK (1) | DK1603565T3 (no) |
EA (1) | EA008828B1 (no) |
ES (1) | ES2309503T3 (no) |
HK (1) | HK1087009A1 (no) |
HR (1) | HRP20050726A2 (no) |
MA (1) | MA27630A1 (no) |
ME (1) | MEP32208A (no) |
MX (1) | MXPA05009007A (no) |
NO (1) | NO20053959L (no) |
NZ (1) | NZ541997A (no) |
PE (1) | PE20050290A1 (no) |
PL (1) | PL377814A1 (no) |
PT (1) | PT1603565E (no) |
RS (1) | RS20050615A (no) |
SA (1) | SA04250122B1 (no) |
SI (1) | SI1603565T1 (no) |
TN (1) | TNSN05186A1 (no) |
UA (1) | UA82217C2 (no) |
WO (1) | WO2004075896A1 (no) |
ZA (1) | ZA200506820B (no) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
US20060257324A1 (en) * | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
JP2007500676A (ja) * | 2003-07-31 | 2007-01-18 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 抗コリン作用薬とベータ受容体刺激薬を含む吸入用薬剤 |
EP1654001A2 (en) * | 2003-08-05 | 2006-05-10 | Boehringer Ingelheim International GmbH | Medicaments for inhalation comprising steroids and a betamimetic |
EP1670482B2 (en) | 2003-09-16 | 2022-06-29 | Covis Pharma B.V. | Use of ciclesonide for the treatment of respiratory diseases |
RU2420285C2 (ru) * | 2005-03-16 | 2011-06-10 | Меда Фарма Гмбх Унд Ко.Кг | Комбинация r,r-гликопирролата и монтелукаста для лечения респираторных заболеваний и фармацевтическая композиция на ее основе |
MX2007012084A (es) * | 2005-03-30 | 2007-11-21 | Schering Corp | Medicamentos y metodos que combinan un anticolinergico, un corticosteroide y un agonista beta de accion prolongada. |
EA013351B1 (ru) * | 2005-08-01 | 2010-04-30 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Фармацевтические препараты, содержащие бета-агонист длительного действия, для введения путем распыления |
ATE529399T1 (de) | 2005-11-10 | 2011-11-15 | Nicholas S Bodor | Sanfte anticholinerge ester |
DE602006008665D1 (de) * | 2005-12-21 | 2009-10-01 | Meda Pharma Gmbh & Co Kg | Kombination von r,r-glycopyrrolat, rolipram und budesonid zur behandlung von entzündungskrankheiten |
WO2007135024A1 (en) * | 2006-05-24 | 2007-11-29 | Boehringer Ingelheim International Gmbh | New long-acting drug combinations for the treatment of respiratory diseases |
EP1953143A1 (en) * | 2007-01-30 | 2008-08-06 | CHIESI FARMACEUTICI S.p.A. | Process for the preparation of 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride |
CL2008000500A1 (es) * | 2007-02-19 | 2008-09-05 | Cipla Ltd | Combinacion farmaceutica que comprende una combinacion de dos o mas broncodilatadores o una combinacion de al menos un broncodilatador y al menos un corticosteroide; uso para tratar o prevenir una enfermedad respiratoria; e inhalador que comprende di |
EP2534957B1 (en) | 2007-12-14 | 2015-05-27 | AeroDesigns, Inc | Delivering aerosolizable products |
EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2309858A4 (en) * | 2008-07-31 | 2011-09-14 | Dekel Pharmaceuticals Ltd | COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES |
WO2010097188A1 (en) * | 2009-02-25 | 2010-09-02 | Chiesi Farmaceutici S.P.A. | Inhalation particles comprising a salt of carmoterol and a corticosteroid |
KR20120023663A (ko) * | 2009-05-25 | 2012-03-13 | 키에시 파르마슈티시 엣스. 피. 에이. | 폐 계면활성제 및 스테로이드를 포함하는 치료적 조합 |
AU2015201037C1 (en) * | 2009-05-29 | 2017-07-27 | Pearl Therapeutics, Inc. | Respiratory delivery of active agents |
LT2435025T (lt) | 2009-05-29 | 2016-09-26 | Pearl Therapeutics, Inc. | Veikliosios medžiagos tiekimas per kvėpavimo takus |
WO2011136753A1 (en) * | 2010-04-26 | 2011-11-03 | Mahmut Bilgic | Combination of carmoterol and fluticasone for use in the treatment respiratory diseases |
CN102247597B (zh) * | 2010-05-19 | 2015-01-07 | 天津金耀集团有限公司 | 一种糖皮质激素与支气管扩张剂的吸入剂 |
AU2011278096B2 (en) * | 2010-07-16 | 2014-08-28 | Cipla Limited | Pharmaceutical compositions comprising R (+) budesonide and one or more bronchodilators |
WO2012010854A1 (en) | 2010-07-23 | 2012-01-26 | Cipla Limited | Inhalation formulations comprising carmoterol in combination with a corticosteroid |
CN102416179B (zh) * | 2010-09-28 | 2014-05-07 | 益得生物科技股份有限公司 | 用于哮喘的吸入性复方组合物 |
TWI399202B (zh) * | 2011-03-17 | 2013-06-21 | Intech Biopharm Ltd | 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法 |
EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
SI2968312T1 (en) * | 2013-03-15 | 2018-06-29 | Verona Pharma PLC Bradley Court | Combination of Medicines |
US10117891B2 (en) | 2014-09-16 | 2018-11-06 | India Globalization Capital, Inc. | Cannabinoid composition for treating pain |
WO2016085933A1 (en) * | 2014-11-24 | 2016-06-02 | The Board Of Trustees Of The University Of Illinois | Method of preventing or treating a pulmonary disease or condition |
US10751300B2 (en) | 2015-01-25 | 2020-08-25 | India Globalization Capital, Inc. | Composition and method for treating seizure disorders |
WO2017027651A1 (en) * | 2015-08-12 | 2017-02-16 | India Globalization Capital, Inc. | Method and composition for treating cachexia and eating disorders |
US11351152B2 (en) | 2016-06-15 | 2022-06-07 | India Globalization Capital, Inc. | Method and composition for treating seizure disorders |
CN115337311B (zh) * | 2022-09-26 | 2023-05-09 | 南京恒道医药科技股份有限公司 | 一种治疗呼吸***疾病的组合物及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5874063A (en) * | 1991-04-11 | 1999-02-23 | Astra Aktiebolag | Pharmaceutical formulation |
SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
ATE284677T1 (de) * | 1997-03-20 | 2005-01-15 | Schering Corp | Herstellung von pulveragglomeraten |
IT1303788B1 (it) * | 1998-11-25 | 2001-02-23 | Chiesi Farma Spa | Formulazioni di aerosol medicinali. |
US20020081266A1 (en) * | 1999-08-20 | 2002-06-27 | Norton Healthcare Ltd. | Spray dried powders for pulmonary or nasal administration |
PE20011227A1 (es) * | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
DZ3358A1 (fr) * | 2000-05-22 | 2001-11-29 | Chiesi Farma Spa | Formulations en solution pharmaceutiques pour inhalateurs-doseurs sous pression |
JP2005523905A (ja) * | 2002-03-01 | 2005-08-11 | キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ | ホルモテロール(formoterol)超微細調合物 |
EP1340492A1 (en) * | 2002-03-01 | 2003-09-03 | CHIESI FARMACEUTICI S.p.A. | Aerosol formulations for pulmonary administration of medicaments having systemic effects |
EP1595531A1 (en) * | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
-
2003
- 2003-02-27 EP EP03004184A patent/EP1452179A1/en not_active Withdrawn
-
2004
- 2004-02-26 PE PE2004000199A patent/PE20050290A1/es not_active Application Discontinuation
- 2004-02-27 US US10/546,619 patent/US20070020190A1/en not_active Abandoned
- 2004-02-27 AR ARP040100620A patent/AR043419A1/es not_active Application Discontinuation
- 2004-02-27 DK DK04715295T patent/DK1603565T3/da active
- 2004-02-27 KR KR1020057014683A patent/KR20050104367A/ko not_active Application Discontinuation
- 2004-02-27 JP JP2006501966A patent/JP2006519204A/ja active Pending
- 2004-02-27 RS YUP-2005/0615A patent/RS20050615A/sr unknown
- 2004-02-27 CA CA002517321A patent/CA2517321A1/en not_active Abandoned
- 2004-02-27 PL PL377814A patent/PL377814A1/pl not_active Application Discontinuation
- 2004-02-27 BR BRPI0408047-5A patent/BRPI0408047A/pt not_active IP Right Cessation
- 2004-02-27 EP EP04715295A patent/EP1603565B1/en not_active Expired - Lifetime
- 2004-02-27 NZ NZ541997A patent/NZ541997A/en unknown
- 2004-02-27 WO PCT/EP2004/001960 patent/WO2004075896A1/en active IP Right Grant
- 2004-02-27 SI SI200430815T patent/SI1603565T1/sl unknown
- 2004-02-27 ME MEP-322/08A patent/MEP32208A/xx unknown
- 2004-02-27 CN CNB2004800053713A patent/CN100370986C/zh not_active Expired - Fee Related
- 2004-02-27 AT AT04715295T patent/ATE401887T1/de not_active IP Right Cessation
- 2004-02-27 EP EP07009204A patent/EP1834643A3/en not_active Withdrawn
- 2004-02-27 UA UAA200507796A patent/UA82217C2/uk unknown
- 2004-02-27 EA EA200501108A patent/EA008828B1/ru not_active IP Right Cessation
- 2004-02-27 AU AU2004216472A patent/AU2004216472B2/en not_active Ceased
- 2004-02-27 DE DE602004015260T patent/DE602004015260D1/de not_active Expired - Lifetime
- 2004-02-27 PT PT04715295T patent/PT1603565E/pt unknown
- 2004-02-27 ES ES04715295T patent/ES2309503T3/es not_active Expired - Lifetime
- 2004-02-27 MX MXPA05009007A patent/MXPA05009007A/es active IP Right Grant
- 2004-02-27 ZA ZA200506820A patent/ZA200506820B/en unknown
- 2004-02-27 CN CNA2007101120284A patent/CN101244063A/zh active Pending
- 2004-05-19 SA SA04250122A patent/SA04250122B1/ar unknown
-
2005
- 2005-07-29 TN TNP2005000186A patent/TNSN05186A1/en unknown
- 2005-08-23 HR HR20050726A patent/HRP20050726A2/xx not_active Application Discontinuation
- 2005-08-25 NO NO20053959A patent/NO20053959L/no not_active Application Discontinuation
- 2005-09-06 MA MA28483A patent/MA27630A1/fr unknown
-
2006
- 2006-06-21 HK HK06107053A patent/HK1087009A1/xx not_active IP Right Cessation
-
2008
- 2008-09-19 CY CY20081101023T patent/CY1108360T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053959L (no) | Medikament omfattende hoy-aktiv langtidsvarende beta-2-aqonist i kombinasjon med andre aktive bestanddeler | |
SG169233A1 (en) | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation | |
EA200500902A1 (ru) | Порошковые лекарственные средства, содержащие соль тиотропия и ксинафоат салметерола | |
ES2187300A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
HUP0402075A2 (hu) | Készítmények nátha kezelésére | |
HUP0401614A2 (hu) | PDE4 inhibitort és antikolinerg hatóanyagot tartalmazó gyógyszerkészítmények és alkalmazásuk | |
EA200501105A1 (ru) | Фармацевтическая композиция | |
HUP0402304A2 (hu) | Deutériummal helyettesített dihidrofuranonszármazékok és azokat tartalmazó gyógyszerkészítmények | |
CA2519679A1 (en) | Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases | |
TNSN05131A1 (en) | New synergistic combination comprising roflumilast and formoterol | |
HUP0400222A2 (hu) | PDE-4 inhibitort és H1 receptor antagonistát tartalmazó kombináció és ennek alkalmazása tüdőbetegségek kezelésére alkalmas gyógyszerkészítmény előállítására | |
SG149876A1 (en) | Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same | |
JP4377564B2 (ja) | 内服用組成物 | |
NO20053023L (no) | Synergistisk kombinasjon omfattende roflumilas og (R,R)-formoterol | |
US20230058134A1 (en) | Aldose reductase inhibitors for the treatment of acute respiratory distress syndrome, acute lung inflammation/injury, cardiac injury and anti-viral therapy | |
EA200500864A1 (ru) | Новый, содержащий тиотропий порошковый препарат для ингаляции | |
HUP0402062A2 (hu) | Alkanoil-L-karnitin alkalmazása merevedési zavar kezelésére és ezt tartalmazó gyógyszerkészítmények | |
DE60308497D1 (de) | Pulverzubereitungen zur inhalation | |
Eccles | Over the counter medicines for colds | |
AU672022B2 (en) | Antiviral combinations | |
BR112023002778A2 (pt) | Ácido (1r,3s)-3-((5-ciano-4-feniltiazol-2-il) carbamoil) ciclopentano-1-carboxílico e derivados do mesmo para uso no tratamento de doenças das vias aéreas | |
TH77905B (th) | ยาชนิดใหม่ซึ่งประกอบรวมด้วย (เบตา)2 -อะโกนิสต์ที่มีการออกฤทธิ์นาน และมีศักยภาพสูงในการใช้ร่วมกับส่วนประกอบออกฤทธิ์อื่นๆ | |
TH77905A (th) | ยาชนิดใหม่ซึ่งประกอบรวมด้วย เบตา2 -อะโกนิสต์ที่มีการออกฤทธิ์นาน และมีศักยภาพสูงในการใช้ร่วมกับส่วนประกอบออกฤทธิ์อื่นๆ | |
JP2001089375A (ja) | 感冒用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |